Viaken Lassoes Sun to Co-Develop and Co-Distribute New Informatics Suite | GenomeWeb

SAN DIEGO, Oct. 26 – Sun Microsystems and Viaken Systems have signed a preliminary agreement to develop and market a new suite of Viaken products, GenomeWeb  has learned on Friday. 

The potential deal, which is open-ended and non-exclusive, is anticipated to close in the current quarter, a Viaken spokesman said at the 13th annual Genome Sequencing and Analysis Conference, held here through Sunday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.